Eintrag
Druckversion der seite
Zu Favoriten hinzufuegen
Eintrag - Anzahl Klicks:
1691
- www.mondobiotech.com
- via Pasquée 23 6925 Gentilino
- 6925 Gentilino
- Schweiz, Switzerland, Suisse, Svizzera, Svizra,
- Prodotti, servizi farmaceutici,
- Pharmazeutische Produkte, Dienstleistungen, Pharmaceutical products, services, Produits, services pharmaceutiques, Prodotti, servizi farmaceutici,
www.mondobiotech.com
.10.2006 mondoBIOTECH Chief Business Architect Fabio Cavalli Swiss Entrepreneur of the Year 2006 mondoBIOTECH's Chief Business Architect Fabio Cavalli winner of the prize Swiss Entrepreneur of the Year 2006 Basel, October 20, 2006 - mondoBIOTECH Chief Business Architect and CEO Fabio Cavalli has been awarded today the Swiss Entrepreneur of the Year 2006 prize for the category "Start up". The Prize is organized every year worldwide by Ernst & Young. mondoBIOTECH has out-licensed to Biogen Idec Inc. (Nasdaq: BIIB) Aviptadil for the treatment of Pulmonary Arterial Hypertension in September 2006. mondoBIOTECH is winner of the Swiss Life Sciences Prize 2005. mondoBIOTECH has out-licensed Interferon-gamma at advanced , clinical stages to InterMune Inc. (Nasdaq: ITMN) for the , treatment of Idiopathic Pulmonary Fibrosis and Severe Asthma Bronchiale. Amphocil® (licensed from InterMune for the Swiss market) for the treatm
.10.2006 mondoBIOTECH Chief Business Architect Fabio Cavalli Swiss Entrepreneur of the Year 2006 mondoBIOTECH's Chief Business Architect Fabio Cavalli winner of the prize Swiss Entrepreneur of the Year 2006 Basel, October 20, 2006 - mondoBIOTECH Chief Business Architect and CEO Fabio Cavalli has been awarded today the Swiss Entrepreneur of the Year 2006 prize for the category "Start up". The Prize is organized every year worldwide by Ernst & Young. mondoBIOTECH has out-licensed to Biogen Idec Inc. (Nasdaq: BIIB) Aviptadil for the treatment of Pulmonary Arterial Hypertension in September 2006. mondoBIOTECH is winner of the Swiss Life Sciences Prize 2005. mondoBIOTECH has out-licensed Interferon-gamma at advanced , clinical stages to InterMune Inc. (Nasdaq: ITMN) for the , treatment of Idiopathic Pulmonary Fibrosis and Severe Asthma Bronchiale. Amphocil® (licensed from InterMune for the Swiss market) for the treatm
| URL 1 : | www.mondobiotech.com |
| Adresse : | via Pasquée 23 6925 Gentilino |
| Agglomeration : | 6925 Gentilino |
| Land / Länder : | Schweiz, Switzerland, Suisse, Svizzera, Svizra, |
| Fachgebiete : | Prodotti, servizi farmaceutici, |
| Dienstleistungen : | Pharmazeutische Produkte, Dienstleistungen, Pharmaceutical products, services, Produits, services pharmaceutiques, Prodotti, servizi farmaceutici, |
- Pharma Pharmacology Schweizer Pharmazeutische Industrie Pharmazeutika Suisse Pharmaceutique Farmaceutica Prodotti farmaceutici Pharmaceutiques médicaments Switzerland Pharmaceutical Industry Medical Medical Research Medicinal Researches and Experiment
- Entreprises de l'industrie du médicament Swiss Pharmaceutical Industries Pharma Industry Pharmaceuticals drugs bulk drugs formulations tablets capsule tablets capsules and pharmaceutical products Experiments
Öffentliche Fragen & Antworten - Login/Anmeldung erforderlich
Zu diesem Eintrag wurden noch keine Fragen gestellt.
Top
|
www.vifor.ch Vifor SA 1752 Villars-sur-Glâne | www.vifor.ch Produits, services... |
Unsere Website-Referenzen 
